RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.


Regulatory Focus™ > News Articles > DHHS Releases New Regulations on Medicaid Covered Outpatient Drugs

DHHS Releases New Regulations on Medicaid Covered Outpatient Drugs

Posted 30 January 2012 | By Alexander Gaffney, RAC 

The US Department of Health and Human Services (DHHS) released new draft regulations on Friday, 27 January that would implement portions of the Patient Protection and Affordable Care Act (PPACA) by revising reimbursement methodologies for outpatient drugs covered by Medicaid.

Medicaid currently allows states to provide coverage of outpatient drugs to patients. Under the PPACA, DHHS is required to adjust the requirements for rebate agreements, drug pricing submission and confidentiality requirements, the formulas for calculating rebate payments, and other various requirements.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.